Parasitaemia prevalence · People of all ages living in an area with moderate to high endemicity of P falciparum malaria (≥ 10% prevalence)
MDA showed no clear difference in parasitaemia prevalence compared with no MDA (low certainty).
1 finding from 1 review
Parasitaemia prevalence · People of all ages living in an area with very low to low endemicity of P falciparum malaria ( < 10% prevalence)
It is very uncertain whether MDA changes parasitaemia prevalence compared with no MDA (very low certainty).
6 findings from 1 review
Show 3 more findings
Parasitaemia prevalence · People of all ages living in an area with very low to low endemicity of P vivax malaria (< 10% prevalence)
MDA may leads to lower parasitaemia prevalence compared with no MDA (low certainty).
6 findings from 1 review
Show 3 more findings
Confirmed malaria illness incidence · People of all ages living in an area with very low to low endemicity of P vivax malaria (< 10% prevalence)
It is very uncertain whether MDA changes confirmed malaria illness incidence compared with no MDA (very low certainty).
1 finding from 1 review
Parasitaemia incidence · People of all ages living in an area with moderate to high endemicity of P falciparum malaria (≥ 10% prevalence)
MDA probably leads to lower parasitaemia incidence compared with no MDA (moderate certainty).
1 finding from 1 review
Confirmed malaria illness incidence · People of all ages living in an area with moderate to high endemicity of P falciparum malaria (≥ 10% prevalence)
MDA showed no clear difference in confirmed malaria illness incidence compared with no MDA (low certainty).
1 finding from 1 review
Parasitaemia incidence · People of all ages living in an area with very low to low endemicity of P falciparum malaria ( < 10% prevalence)
MDA probably leads to lower parasitaemia incidence compared with no MDA (moderate certainty).
1 finding from 1 review
Confirmed malaria illness incidence · People of all ages living in an area with very low to low endemicity of P falciparum malaria ( < 10% prevalence)
It is very uncertain whether MDA changes confirmed malaria illness incidence compared with no MDA (very low certainty).
2 findings from 1 review
NFCS pain score during the procedure№ of infants: 112(2 RCTs) Score · procedural pain in neonates
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain score assessed up to 10 minutes after the procedure · procedural pain in neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of bradycardia · procedural pain in neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of apnea · procedural pain in neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypotension requiring medical therapy (vasopressors or fluid boluses), occurring during the procedure · procedural pain in neonates
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of mortality · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
It is very uncertain whether MDAC + hospital intervention changes incidence of mortality compared with SDAC + hospital intervention (very low certainty).
1 finding from 1 review
Incidence of adverse events · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
MDAC + hospital intervention may leads to higher incidence of adverse events compared with SDAC + hospital intervention (low certainty).
1 finding from 1 review
Incidence and severity of symptoms of poisoning: incidence of need for intubation · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
MDAC + hospital intervention showed no clear difference in incidence and severity of symptoms of poisoning: incidence of need… compared with SDAC + hospital intervention (low certainty).
1 finding from 1 review
Duration of intubation · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
1 finding from 1 review
Drug absorption: cardenolide: AUC (µg × L/h) · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
1 finding from 1 review
Hospitalization · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of admissions to the ICU · first aid in patients with acute oral poisoning (carbamazepine, yellow oleander, or combinations of different drugs)
MDAC + hospital intervention may leads to lower incidence of ICU admission compared with SDAC + hospital intervention (low certainty).
1 finding from 1 review